Actively Recruiting
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Led by M.D. Anderson Cancer Center · Updated on 2026-03-03
12000
Participants Needed
1
Research Sites
1095 weeks
Total Duration
On this page
Sponsors
M
M.D. Anderson Cancer Center
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study performs standardized testing of tumor tissue samples to learn which genes are mutated (have changed) in order to provide personalized cancer therapy options to cancer patients at MD Anderson. This may help doctors use testing information on tumors to identify clinical trials that may be most relevant to patients. Researchers may also use the information learned from this study to develop a database of the different kinds of mutations in cancer-related genes.
CONDITIONS
Official Title
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must have histologically, radiographic, or cytologically documented cancer, suspected glioma, sarcoma, melanoma or hematologic cancer. Patients with benign tumors may also be consented if molecular profiling may have clinical implications.
- Patients must have the ability to understand and the willingness to sign a written informed consent document.
- Patients may be consented without confirming tissue availability, but research testing requires sufficient archived or residual tissue in authorized MD Anderson tissue banks.
- Circulating cell-free DNA next generation sequencing testing will be performed for select patients being considered for enrollment into clinical trials in the next two lines of therapy.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
F
Funda Meric-Bernstam, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here